Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Protective Role of Hypoxia-Inducible Factor-2α against Ischemic Damage and Oxidative Stress in the Kidney
2007
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
Nitric Oxide and the Cardiovascular System
1994
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
Nitric oxide and its role in the cardiovascular system
1995
Vascular Calcification Mechanisms
2004 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab
2006
Mechanisms of hypoxia signalling: new implications for nephrology
2019 StandoutNobel
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
2008 Standout
Update on Mechanisms of Ischemic Acute Kidney Injury
2006
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability
2010
Effect of the platelet‐activating factor antagonist, TCV‐309, and the cyclo‐oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock
1993 StandoutNobel
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Vitamin D Deficiency
2007 Standout
Polycystic kidney disease
2018
Coexistence of atypical hemolytic uremic syndrome and crescentic IgA nephropathy treated with eculizumab: a case report
2016
Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis
2009
B-cell depletion with rituximab in the treatment of autoimmune diseases
2007
Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic Syndrome
2017
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
2004 Standout
Data Resource Profile: The Danish National Prescription Registry
2016 Standout
Acute Effects of Nicotine Infusion on Platelets in Nicotine Users with Normal and Impaired Renal Function
2000 StandoutNobel
Wegener Granulomatosis With Massive Intracerebral Hemorrhage
2005
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
2020 Standout
Time course of some effects of cigarette smoking on platelets
1992
Herbal Medicinals
1998 Standout
The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment
2011
Effect of N-Nitro-L-Arginine on Effective Vascular Stiffness in Dogs
1993 StandoutNobel
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
2011 StandoutNobel
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE
2006
Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
2016 StandoutNobel
The Danish National Patient Registry: a review of content, data quality, and research potential
2015 Standout
The Effects of Sevelamer and Calcium Acetate on Proxies of Atherosclerotic and Arteriosclerotic Vascular Disease in Hemodialysis Patients
2003
Atypical Hemolytic Uremic Syndrome Associated with Complement Factor H Mutation and IgA Nephropathy: A Case Report Successfully Treated with Eculizumab
2017
The pathophysiology of cigarette smoking and cardiovascular disease
2004 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review
2007
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Plasma Exchange as an Adjunctive Therapy for Crescentic IgA Nephropathy
2016
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome
2006
Preservation of endothelium-dependent vasodilation with low-potassium university of wisconsin solution
1996 StandoutNobel
Albumin‐corrected calcium and ionized calcium in stable haemodialysis patients
2000
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients
1996
Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2
2013 StandoutNobel
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Chronic Kidney Disease
2016 Standout
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Phosphate Metabolism in the Setting of Chronic Kidney Disease: Significance and Recommendations for Treatment
2007
Bartter’s and Gitelman’s Syndromes: From Gene to Clinic
2004
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Rituximab for Refractory Wegener's Granulomatosis
2005
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Arteriovenous fistula thrombosis in patients on regular hemodialysis: a report of 171 patients.
2006
Ginger: Inhibition of thromboxane synthetase and stimulation of prostacyclin: Relevance for medicine and psychiatry
1986
Effect of Smoking on Cerebrovascular Reactivity
1996
Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis
2019 Standout
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
2011
Effects of chronic smoking on platelet function
1987
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Thromboembolic Phenomena and the use of the Pig as an Appropriate Animal Model for Research on Cardiovascular Devices
1997 StandoutNobel
Erythropoietin receptors: their role beyond erythropoiesis
2005
Guidelines for the Primary Prevention of Stroke
2014 Standout
Preferential venoconstriction by cyclooxygenase inhibition in vivo without attenuation of nitroglycerin venodilation.
1988
SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty.
1993
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy
2014
Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury
2009
Bone metabolism and disease in chronic kidney disease
2003
Works of Troels Ring being referenced
Reevaluation of the criteria for the clinical diagnosis of Gitelman syndrome
2002
Rituximab Induced Remission in a Patient with Wegener’s Granulomatosis
2005
EPO and α-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney
2004
Successful treatment of a patient with primary Sjögren's syndrome with Rituximab
2005
Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?
2015
Risk of intracranial aneurysm bleeding in autosomal-dominant polycystic kidney disease
2007
Validity of the International Classification of Diseases, 10th revision discharge diagnosis codes for hyponatraemia in the Danish National Registry of Patients
2014
Cigarette smoking shortens the bleeding time
1983
Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysis.
1984
Eculizumab in Atypical Hemolytic-Uremic Syndrome
2013
Calcium acetate versus calcium carbonate as phosphorus binders in patients on chronic haemodialysis: a controlled study
1993
Calcium in patients on hemodialysis.
1995
Nitroglycerin prolongs the bleeding time in healthy males
1983